They once struggled for funding. Now, Carl June and researchers at the University of Pennsylvania are drawing attention for a trial that uses gene therapy—engineered T cells—to fight cancer: “In their natural state, T cells usually aren’t able to kill tumor cells, partly because they can’t latch on strongly enough. But June was fascinated by […]
No comments yet.
Sign in to comment.
Other articles with overlapping topics.